City of Industry, CA, January 15, 2015 – AIDP receives final approval from FDA for proprietary ingredient Magnesium L-threonate; further underscores MagteinTM safety for cognitive health and Alzheimer's disease.
Dr. Guosong Liu, the principal investigator behind MagteinTM, from MIT, UCLA, Tsinghua University and the University of Texas at Austin, explains MagteinTM’s mechanism of action and the early discoveries.
AIDP Inc. will be exhibiting at Ingredient Marketplace Orlando. FL, Booth #407 April 8-9, 2015. Magtein will be featured during this tradeshow.
MagteinTM products deliver a strong repeat rate since consumers feel a difference in their life. Read what consumers are saying about MagteinTM.
MagteinTM (Magnesium L-threonate) is a breakthrough super-mineral with strong evidence supporting cognitive functions and brain health.
MagteinTM, a unique, patented compound discovered by MIT scientists, has been shown in animal studies to restore aging neurons to their youthful conditions.
The brain naturally undergoes gradual structural and functional changes as we age. The good news is, the adult brain is capable of a greater degree of plasticity than scientists have previously believed. Old neurons, even in the brain regions responsible for learning and memory, can restore synaptic density, leading to improvement of attention, working memory, short- and long-term memory, reduction of anxiety, and improved sleep quality.